[Lamivudine resistance impedes hepatitis B therapy].
Eggers
H J
HJ
D004352:Drug Resistance, Microbial; D006509:Hepatitis B / Q000188:drug therapy*; D006515:Hepatitis B virus / Q000187:drug effects*; D006801:Humans; D019259:Lamivudine / Q000009:adverse effects / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine
Lamivudinresistenz behindert Hepatitis-B-Therapie.